Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 4 hours 39 minutes
NIKKEI 225
38,180.44
-93.61
(-0.24%)
HANG SENG
17,921.70
+158.67
(+0.89%)
CRUDE OIL
79.32
+0.32
(+0.41%)
GOLD FUTURES
2,334.70
+23.70
(+1.03%)
DOW
37,903.29
+87.37
(+0.23%)
Bitcoin GBP
45,749.15
-1,896.46
(-3.98%)
Money
Family finances
Who is the breadwinner in your family and does it matter?
Allogene Therapeutics, Inc. (ALLO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9200
+0.1600
(+5.80%)
At close: 04:00PM EDT
2.9200
0.00
(0.00%)
After hours:
04:13PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
95
95
156
114,089
0
Operating expenses
Research development
242,914
242,914
256,387
220,176
192,987
Selling general and administrative
71,673
71,673
79,305
74,105
65,256
Total operating expenses
314,587
314,587
335,692
294,281
258,243
Operating income or loss
-314,492
-314,492
-335,536
-180,192
-258,243
Interest expense
-
-
-
-
0
Total other income/expenses net
-31,080
-31,080
-9,444
-3,573
-67,302
Income before tax
-327,265
-327,265
-340,414
-182,051
-316,381
Income tax expense
-
-
-
0
0
Income from continuing operations
-327,265
-327,265
-340,414
-182,051
-316,381
Net income
-327,265
-327,265
-340,414
-182,051
-316,381
Net income available to common shareholders
-327,265
-327,265
-340,414
-182,051
-316,381
Basic EPS
-2.20
-
-2.38
-1.34
-2.63
Diluted EPS
-2.20
-
-2.38
-1.34
-2.63
Basic average shares
150,856
-
143,147
135,820
120,370
Diluted average shares
150,856
-
143,147
135,820
120,370
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.